238 related articles for article (PubMed ID: 32080970)
1. A lncRNA survey finds increases in neuroprotective LINC-PINT in Parkinson's disease substantia nigra.
Simchovitz A; Hanan M; Yayon N; Lee S; Bennett ER; Greenberg DS; Kadener S; Soreq H
Aging Cell; 2020 Mar; 19(3):e13115. PubMed ID: 32080970
[TBL] [Abstract][Full Text] [Related]
2. NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress.
Simchovitz A; Hanan M; Niederhoffer N; Madrer N; Yayon N; Bennett ER; Greenberg DS; Kadener S; Soreq H
FASEB J; 2019 Oct; 33(10):11223-11234. PubMed ID: 31311324
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease.
Ni Y; Huang H; Chen Y; Cao M; Zhou H; Zhang Y
Cell Mol Neurobiol; 2017 Mar; 37(2):329-338. PubMed ID: 27151187
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival.
Feng H; Zhang J; Shi Y; Wang L; Zhang C; Wu L
J Cell Biochem; 2019 Jun; 120(6):9594-9600. PubMed ID: 30569513
[TBL] [Abstract][Full Text] [Related]
5. Long intragenic non-coding RNA p53-induced transcript (LINC-PINT) as a novel prognosis indicator and therapeutic target in cancer.
He T; Yuan C; Zhao C
Biomed Pharmacother; 2021 Nov; 143():112127. PubMed ID: 34474342
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.
Liu W
Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482
[No Abstract] [Full Text] [Related]
7. PINTology: A short history of the lncRNA LINC-PINT in different diseases.
Bukhari I; Khan MR; Hussain MA; Thorne RF; Yu Y; Zhang B; Zheng P; Mi Y
Wiley Interdiscip Rev RNA; 2022 Jul; 13(4):e1705. PubMed ID: 35019222
[TBL] [Abstract][Full Text] [Related]
8. LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1).
Zhou X; Wang Y; Li Q; Ma D; Nie A; Shen X
Biochem Biophys Res Commun; 2020 Sep; 530(1):47-53. PubMed ID: 32828314
[TBL] [Abstract][Full Text] [Related]
9. Expression signatures of long non-coding RNA in the substantia nigra of pre-symptomatic mouse model of Parkinson's disease.
Jiao F; Wang Q; Zhang P; Bu L; Yan J; Tian B
Behav Brain Res; 2017 Jul; 331():123-130. PubMed ID: 28476570
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC-PINT increases SOCS1 expression by sponging miR-155-5p to inhibit the activation of ERK signaling pathway in rheumatoid arthritis synovial fibroblasts induced by TNF-α.
Wang J; Zhao Q
Int Immunopharmacol; 2020 Jul; 84():106497. PubMed ID: 32289665
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing.
Soreq L; Guffanti A; Salomonis N; Simchovitz A; Israel Z; Bergman H; Soreq H
PLoS Comput Biol; 2014 Mar; 10(3):e1003517. PubMed ID: 24651478
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis.
Yuan Z; Xiu C; Liu D; Zhou G; Yang H; Pei R; Ding C; Cui X; Sun J; Song K
J Cell Physiol; 2019 Dec; 234(12):23111-23122. PubMed ID: 31131448
[TBL] [Abstract][Full Text] [Related]
13. Paraquat and MPTP induce alteration in the expression profile of long noncoding RNAs in the substantia nigra of mice: Role of the transcription factor Nrf2.
Wang L; Yang H; Wang Q; Zhang Q; Wang Z; Zhang Q; Wu S; Li H
Toxicol Lett; 2018 Jul; 291():11-28. PubMed ID: 29627306
[TBL] [Abstract][Full Text] [Related]
14. The aberrantly expressed long non-coding RNA in the substantia nigra and corpus striatum of Nrf2-knockout mice.
Liu J; Xu Y; Kang Y; Cao S; Shi G; Cui H; Sun S; Wang L
J Neurochem; 2017 Oct; 143(1):65-75. PubMed ID: 28771719
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Long Noncoding RNA Linc-Pint by Hepatitis C Virus in Infected Hepatocytes Enhances Lipogenesis.
Khatun M; Sur S; Steele R; Ray R; Ray RB
Hepatology; 2021 Jul; 74(1):41-54. PubMed ID: 33236406
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO.
Chen J; Zhu M; Zou L; Xia J; Huang J; Deng Q; Xu R
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):801-809. PubMed ID: 32632453
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4.
Zhang L; Hu J; Li J; Yang Q; Hao M; Bu L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1595-1602. PubMed ID: 31010333
[TBL] [Abstract][Full Text] [Related]
18. LINC-PINT alleviates lung cancer progression via sponging miR-543 and inducing PTEN.
Wang S; Jiang W; Zhang X; Lu Z; Geng Q; Wang W; Li N; Cai X
Cancer Med; 2020 Mar; 9(6):1999-2009. PubMed ID: 31981466
[TBL] [Abstract][Full Text] [Related]
19. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p].
Yang H; Cao C; Wang LJ
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):325-330. PubMed ID: 32375449
[No Abstract] [Full Text] [Related]
20. lncRNA LINC-PINT is downregulated in melanoma and regulates cell proliferation by downregulating lncRNA BANCR.
Huang Q; Zhang D; Diao Q; Lin M
Oncol Lett; 2019 Sep; 18(3):2917-2922. PubMed ID: 31452772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
